JP6832276B2 - 薬剤の眼内送達 - Google Patents

薬剤の眼内送達 Download PDF

Info

Publication number
JP6832276B2
JP6832276B2 JP2017523822A JP2017523822A JP6832276B2 JP 6832276 B2 JP6832276 B2 JP 6832276B2 JP 2017523822 A JP2017523822 A JP 2017523822A JP 2017523822 A JP2017523822 A JP 2017523822A JP 6832276 B2 JP6832276 B2 JP 6832276B2
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
group
composition according
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017523822A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017533228A (ja
JP2017533228A5 (https=
Inventor
ウチェグブ、イジェオマ
スチャツレイン、アンドレアス
カプレット、ロレンツォ
Original Assignee
ナノメリクス リミテッド
ナノメリクス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ナノメリクス リミテッド, ナノメリクス リミテッド filed Critical ナノメリクス リミテッド
Publication of JP2017533228A publication Critical patent/JP2017533228A/ja
Publication of JP2017533228A5 publication Critical patent/JP2017533228A5/ja
Application granted granted Critical
Publication of JP6832276B2 publication Critical patent/JP6832276B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2017523822A 2014-11-03 2015-11-02 薬剤の眼内送達 Active JP6832276B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1419540.8 2014-11-03
GBGB1419540.8A GB201419540D0 (en) 2014-11-03 2014-11-03 Delivery of drugs
PCT/GB2015/053291 WO2016071677A1 (en) 2014-11-03 2015-11-02 Ocular delivery of drugs

Publications (3)

Publication Number Publication Date
JP2017533228A JP2017533228A (ja) 2017-11-09
JP2017533228A5 JP2017533228A5 (https=) 2018-11-29
JP6832276B2 true JP6832276B2 (ja) 2021-02-24

Family

ID=52118610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017523822A Active JP6832276B2 (ja) 2014-11-03 2015-11-02 薬剤の眼内送達

Country Status (7)

Country Link
US (2) US10987304B2 (https=)
EP (1) EP3215119B1 (https=)
JP (1) JP6832276B2 (https=)
CN (2) CN116392600A (https=)
CA (1) CA2966592C (https=)
GB (1) GB201419540D0 (https=)
WO (1) WO2016071677A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014117035A1 (en) 2013-01-24 2014-07-31 Transderm, Inc. COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS
JP7108631B2 (ja) 2017-01-06 2022-07-28 パルヴェラ セラピューティクス、インク． ｍＴＯＲ阻害剤の無水組成物およびその使用方法
KR102810631B1 (ko) * 2018-02-26 2025-05-23 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. 약물 전달 시스템
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
GB202007703D0 (en) 2020-05-22 2020-07-08 Nanomerics Ltd Amphiphilic carbohydrate compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
US6395756B2 (en) * 1999-12-23 2002-05-28 Novartis Ag Use of ophthalmic agent
DE10242080A1 (de) * 2002-09-11 2004-03-25 Degussa Ag Verfahren zur Katalysator-freien Herstellung von Cyanophenolen aus Methoxybenzonitrilen
GB0221941D0 (en) 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps
GB0615834D0 (en) 2006-08-09 2006-09-20 Univ Glasgow Polymeric micellar clusters and their uses in formulating drugs

Also Published As

Publication number Publication date
US20210212938A1 (en) 2021-07-15
CN116392600A (zh) 2023-07-07
CA2966592A1 (en) 2016-05-12
EP3215119B1 (en) 2021-03-10
JP2017533228A (ja) 2017-11-09
EP3215119A1 (en) 2017-09-13
CN107106487A (zh) 2017-08-29
CA2966592C (en) 2023-03-07
US10987304B2 (en) 2021-04-27
GB201419540D0 (en) 2014-12-17
US20170326064A1 (en) 2017-11-16
WO2016071677A1 (en) 2016-05-12

Similar Documents

Publication Publication Date Title
Zeng et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability
Shen et al. Preparation and ocular pharmacokinetics of ganciclovir liposomes
Li et al. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery
Elmowafy et al. Exploring optimized methoxy poly (ethylene glycol)-block-poly (ε-caprolactone) crystalline cored micelles in anti-glaucoma pharmacotherapy
US20210212938A1 (en) Ocular delivery of drugs
Pleyer et al. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye.
He et al. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels
JP6824270B2 (ja) 生物活性親油性化合物を有するｐｅｇ化脂質ナノ粒子
US9901544B2 (en) Membrane-adherent self-assembled system for treatment of ocular disorders
IL266964B1 (en) Preparations containing complexes of cyclodextrin in solid state and an active substance for ophthalmic administration
PT1809238E (pt) Emulsões oftálmicas contendo um agente imunossupressor
WO2006117666A2 (en) Dosage forms, pharmaceutical compositions and methods for sub-tenon delivery
HK1235697A1 (en) Ocular delivery of drugs
HK1235697B (en) Ocular delivery of drugs
Badr Topical Ocular Delivery to Posterior Eye Tissues
Maw Development of cyclodextrin-based pickering nanoemulsion containing amphotericin b for treatment of fungal keratitis
Manasa et al. FORMULATION AND EVALUATION OF MOXIFLOXACIN OCULAR MICROEMULSION GEL
HK1234413A1 (en) Membrane-adherent self-assembled systems for treatment of ocular disorders
HK1234413B (zh) 用於治療眼部病症的膜附著性自組裝體系

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170705

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20170705

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181018

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181018

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190820

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200602

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200901

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201027

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210201

R150 Certificate of patent or registration of utility model

Ref document number: 6832276

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250